跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Irican
Approved
STANDARD
Irican
Jiangsu Hengrui Medicine Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
491d7d73ab815ea4
Company
Jiangsu Hengrui Medicine Co., Ltd.
Type
Standard
Approval Details
Approval Id
491d7d73ab815ea4
Drug Approval Philippines Name
Irican
Product Name
Irican
Registration Number
DR-XY48013
Brand Name
Irican
Generic Name
Irinotecan hydrochloride
Dosage Form
Solution for IV Infusion
Dosage Strength
20 mg/mL
Manufacturer
Jiangsu Hengrui Medicine Co., Ltd.
Importer
Phil. Pharmawealth, Inc.
Distributor
Phil. Pharmawealth, Inc.
Company Detail Path
/organization/jiangsu-hengrui-medicine-co-ltd
Issuance Date
12 May 2022
Expiry Date
12 May 2027
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
491d7d73ab815ea4
Type
Standard
Back to Philippines FDA Approvals
Irican - Philippines FDA Drug Approval Details